The company’s shares closed last Tuesday at $2.81, equals to its 52-week low of $2.81.
Nanosonics Limited has an analyst consensus of Moderate Sell, with a price target consensus of $3.42, implying a 19.2% upside from current levels. In a report issued on February 9, Morgans also maintained a Buy rating on the stock with a price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $5.16 and a one-year low of $2.81. Currently, Nanosonics Limited has an average volume of 142.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nanosonics Ltd is an Australia based healthcare equipment manufacturing company. It manufactures and distributes the trophon EPR ultrasound probe disinfector, which reduces the risk of ultrasound-related cross-infection. It also manufactures the associated consumables and accessories such as the trophon wall mount, trophon printer, trophon cart, trophon curved probe positioner and others. In addition, the company manufactures and commercializes infection control and decontamination products and services and related technologies. The entity operates in Australia and other countries, of which key revenue is derived from North America.
Read More on NNCSF:
- ELMO Software Ltd. (ELMFF) Receives a Buy from Shaw and Partners
- Northern Star Resources Ltd (NESRF) Gets a Buy Rating from Ord Minnett
- Bell Potter Upgrades Nanosonics Limited (NNCSF) to Hold
- Australia and New Zealand Banking Group Limited (ANEWF) Gets a Buy Rating from UBS
- UBS Sticks to Their Sell Rating for AMP Limited (AMLTF)
